[Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions]

MeSH terms

• Adenocarcinoma, Follicular / blood
• Adenocarcinoma, Follicular / radiotherapy
• Adenocarcinoma, Follicular / surgery
• Adenocarcinoma, Follicular / therapy*
• Autoantibodies / blood
• Biomarkers, Tumor / blood
• Carcinoma, Papillary / blood
• Carcinoma, Papillary / radiotherapy
• Carcinoma, Papillary / surgery
• Carcinoma, Papillary / therapy*
• Case Management*
• Follow-Up Studies
• Humans
• Iodine Radioisotopes / administration & dosage
• Iodine Radioisotopes / therapeutic use
• Neoplasm Metastasis
• Neoplasm Recurrence, Local / diagnosis
• Positron-Emission Tomography
• Radiopharmaceuticals
• Radiotherapy Dosage
• Recombinant Proteins / pharmacology
• Risk
• Thyroglobulin / blood
• Thyroid Neoplasms / blood
• Thyroid Neoplasms / radiotherapy
• Thyroid Neoplasms / surgery
• Thyroid Neoplasms / therapy*
• Thyroidectomy
• Thyrotropin / blood
• Thyrotropin / pharmacology